Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis.
Nei T, Urano S, Motoi N, Takizawa J, Kaneko C, Kanazawa H, Tazawa R, Nakagaki K, Akagawa KS, Akasaka K, Ichiwata T, Azuma A, Nakata K. Nei T, et al. Among authors: takizawa j. Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L959-64. doi: 10.1152/ajplung.00378.2011. Epub 2012 Feb 24. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22367782 Free article.
Possible Involvement of Lung Cells Harboring an Abnormal Karyotype in the Pathogenesis of Pulmonary Alveolar Proteinosis Associated with Myelodysplastic Syndrome.
Moriyama M, Yano T, Furukawa T, Takada T, Ushiki T, Masuko M, Takizawa J, Sone H, Tazawa R, Saijo Y, Ishii H, Nakata K. Moriyama M, et al. Among authors: takizawa j. Ann Am Thorac Soc. 2015 Aug;12(8):1251-3. doi: 10.1513/AnnalsATS.201503-175LE. Ann Am Thorac Soc. 2015. PMID: 26317278 No abstract available.
Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.
Furukawa T, Kurasaki-Ida T, Masuko M, Tsukada N, Okazuka K, Sato N, Yano T, Abe T, Momoi A, Shibasaki Y, Higashimura M, Karimata K, Moriyama M, Kuroha T, Takizawa J, Toba K, Narita M, Fuse I, Takahashi M, Aizawa Y. Furukawa T, et al. Among authors: takizawa j. Int J Hematol. 2010 Jul;92(1):144-51. doi: 10.1007/s12185-010-0610-0. Epub 2010 Jun 9. Int J Hematol. 2010. PMID: 20533008 Clinical Trial.
Manifestations of fulminant CD8 T-cell post-transplant lymphoproliferative disorder following the administration of rituximab for lymphadenopathy with a high level of Epstein-Barr Virus (EBV) replication after allogeneic hematopoietic stem cell transplantation.
Tanaka T, Takizawa J, Miyakoshi S, Kozakai T, Fuse K, Shibasaki Y, Moriyama M, Ohshima K, Toba K, Furukawa T, Sone H, Masuko M. Tanaka T, et al. Among authors: takizawa j. Intern Med. 2014;53(18):2115-9. doi: 10.2169/internalmedicine.53.2384. Epub 2014 Sep 15. Intern Med. 2014. PMID: 25224199 Free article.
The association of level of reduction of Wilms' tumor gene 1 mRNA transcript in bone marrow and outcome in acute myeloid leukemia patients.
Shibasaki Y, Seki Y, Tanaka T, Miyakoshi S, Fuse K, Kozakai T, Kobayashi H, Ushiki T, Abe T, Yano T, Moriyama M, Kuroha T, Isahai N, Takizawa J, Narita M, Koyama S, Furukawa T, Sone H, Masuko M. Shibasaki Y, et al. Among authors: takizawa j. Leuk Res. 2015 Jun;39(6):667-71. doi: 10.1016/j.leukres.2015.03.021. Epub 2015 Apr 7. Leuk Res. 2015. PMID: 25890432 Clinical Trial.
105 results